After confirming the feasibility of the triple-AAV approach for cochlear gene delivery, we evaluated the effect of administering triple Cdh23-AAV vectors in a mouse model of human CDH23-related HL. This evidence concerns the gene CDH23 and Hodgkins lymphoma.